Smo Clinplus Co., Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Prius (Shanghai) Pharmaceutical Technology Development Co., Ltd. provides SMO services to domestic and foreign pharmaceutical companies, medical device companies, and some clinical research and development of health related products. Based on the accumulated experience in clinical trial project execution in the past, and based on the characteristics of different clinical trial projects, we establish a highly operational and feasible clinical trial project execution plan, providing customers with preliminary preparation plans, trial site initiation, on-site execution Provide comprehensive project management and other services to achieve a one-stop service for clinical trial outsourcing management, thereby more efficiently and quickly promoting the landing and execution of clinical trials by the sponsor. |
| Headquarter | Shanghai |
| Establish Date | 2/22/2013 |
| Listed Code | 301257.SZ |
| Listed Date | 5/17/2022 |
| Chairman | Lai Chunbao. |
| CEO | Yang Hongwei. |
| Website | www.smo-clinplus.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
